WebMar 31, 2024 · Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused primarily on developing biological therapeutics for eye diseases. The company is developing a novel... WebFeb 10, 2024 · Opthea Limited is an Australia-based clinical-stage biopharmaceutical company. The Company is focused on developing novel therapies to treat highly prevalent and progressive retinal eye diseases including wet age-related macu lar degeneration (wet AMD) and diabetic macular edema (DME). The Company’s lead product candidate OPT …
OPT Opthea Ltd. ADR Stock Price & News - WSJ
WebStock analysis for Opthea Ltd (OPT:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Web167 0 [Opthea Ltd ADR吧] Home Country News Release - Request for Volutary Suspension Opthea Ltd A 06-07 00:00 06-07 00:00; 142 0 [Opthea Ltd ADR吧] Home Country News Release - Confirmation of Suspension Opthea Ltd A 06-07 00:00 06-07 00:00; 99 0 [开市客吧] Quarterly report [Sections 13 or 15(d)] 开市客资讯 06-06 00:00 06-06 00:00 simplify b x b
Explore Opthea Ltd ESG score, report and breaking news
WebCompany Summary. Opthea Limited, a clinical stage biopharmaceutical company, develops and commercializes therapies primarily for eye disease in Australia. The company's … WebGet the latest Opthea Ltd (OPT) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. WebMar 6, 2024 · Opthea Ltd (ADR) does not have a meaningful P/E due to negative earnings over the last 12 trailing months. Opthea Ltd (ADR)’s trailing 12-month revenue is $1.2 million with a % profit margin. Year-over-year quarterly sales growth most recently was 500.0%. There are not analysts providing consensus earnings estimates for the current fiscal year. simplify by adding like terms